510(k) Report

510(k) · Cleared

Cleared

Calmatrix Calcium Sulfate Bone Graft Binder

K041324510(k) TraditionalCleared Jul 19, 200462-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lifecore Biomedical, Inc. · LYC Bone Grafting Material, Synthetic

Cleared on Jul 19, 2004 as substantially equivalent to K955096 (Lifecore Biomedical, Inc., 1996) and 1 other predicate after a 62-day review. Its family tree reaches back 1 generation to 1996. 4 later devices descend from it.

Decided
Jul 19, 2004
Review
62 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K955096 (1996). 2 ancestors in all. 4 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2013: 1 descendant cleared2006: 1 descendant cleared2012: 1 descendant cleared2011: 1 descendant clearedK955096 · Capset Calcium Sulfate Bone Graft Plaster · Lifecore Biomedical, Inc. · 19961995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 3 descendants2 generations forward: 1 descendant K955096 · Capset Calcium Sulfate Bone Graft Plaster · Lifecore Biomedical, Inc. · 19960
  1. Root · 1 generation backK955096 Capset Calcium Sulfate Bone Graft PlasterLifecore Biomedical, Inc. · 1996
  2. This deviceK041324 Calmatrix Calcium Sulfate Bone Graft BinderLifecore Biomedical, Inc. · 2004
  3. Descendant · cites it directly · 1 of its ownK060285 Bonegen - TRBio-Lok Intl., Inc. · 2006
  4. Descendant · cites it directly · 0 of its ownK131385 Easy-GraftDegradable Solutions AG · 2013
  5. Descendant · cites it directly · 0 of its ownK113049 Socket GraftSteiner Laboratories · 2012
  6. Descendant · 2 generations on · 0 of its ownK102208 NanogenOrthogen, LLC · 2011

Most influential descendants

Showing 4 of 4 · See all
  • K060285Bonegen - TRBio-Lok Intl., Inc. · 2006 · cites it directly1descendant
  • K131385Easy-GraftDegradable Solutions AG · 2013 · cites it directly0descendants
  • K113049Socket GraftSteiner Laboratories · 2012 · cites it directly0descendants
  • K102208NanogenOrthogen, LLC · 2011 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K955096Capset Calcium Sulfate Bone Graft PlasterLifecore Biomedical, Inc.1996—
0 (this device)K041324Calmatrix Calcium Sulfate Bone Graft BinderLifecore Biomedical, Inc.2004—
+1K060285Bonegen - TRBio-Lok Intl., Inc.2006—
+1K131385Easy-GraftDegradable Solutions AG2013—
+1K113049Socket GraftSteiner Laboratories2012—
+2K102208NanogenOrthogen, LLC2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
201110
201210
201310
FIG. 1 — Lineage of K041324, 1996–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955096Capset Calcium Sulfate Bone Graft Plaster
Summary page 1
…Plaster of Paris has been determined. Reference FDA Publication 91-4246. Identification of CAPSET Calcium Sulfate Bone Graft Barrier (K955096) Equivalent Devices ALLOMATRIX® Putty (K020895) 3. Device Description Lifecore Biomedical CalMatrix Calcium Sulfate Bone G…
Lifecore Biomedical, Inc.1996—
*K020895Allomatrix Model# 86
Summary page 1
…en determined. Reference FDA Publication 91-4246. Identification of CAPSET Calcium Sulfate Bone Graft Barrier (K955096) Equivalent Devices ALLOMATRIX® Putty (K020895) 3. Device Description Lifecore Biomedical CalMatrix Calcium Sulfate Bone Graft Binder (CalMatrix) is a calcium sulfate materia…
Wrightmedicaltechnologyinc2004—

Also cleared against K955096: 1 other device →

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060285Bonegen - TRBio-Lok Intl., Inc.20061
K131385Easy-GraftDegradable Solutions AG20130
K113049Socket GraftSteiner Laboratories20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K060285 (Bio-Lok Intl., Inc., 2006) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K955096.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

CalMatrix Calcium Sulfate Bone Graft Binder, when mixed with allograft or other bone graft material, may be used to treat multiple types of maxillary and mandibular osseous and periodontal defects such as: * Intrabony/infrabony defects · Furcation defects * Recession defects * Dehiscence/fenestration defects (natural teeth and prosthetic root form implants) · Extraction socket (ridge preservation) defects • Ridge augmentation defects · Sinus lift defects…

Read the full statement (168 words)

CalMatrix Calcium Sulfate Bone Graft Binder, when mixed with allograft or other bone graft material, may be used to treat multiple types of maxillary and mandibular osseous and periodontal defects such as:

* Intrabony/infrabony defects

· Furcation defects

* Recession defects

* Dehiscence/fenestration defects (natural teeth and prosthetic root form implants)

· Extraction socket (ridge preservation) defects

• Ridge augmentation defects

· Sinus lift defects

* Endodontic bony defects

After site preparation in the usual manner, select an appropriately sized package of CalMatrix Binder to go with the quantity of bone graft material of choice selected to treat the defect size. Combine the two dry ingredients, add the syringe liquid provided in the CalMatrix package and mix. Place the composite graft into the prepared defect site and suture the soft tissue flaps back in the usual manner or as dictated by clinical expertise. The graft material may be covered by a barrier or membrane prior to suture placement if, in the judgment of the clinician, it is indicated.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041324: Calmatrix Calcium Sulfate Bone Graft Binder.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K041324

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026